Comparing migraine prevention treatments in primary care
Treatments studied
Part of Brain & nervous system clinical trials.
This trial compares two first-line migraine prevention medications in primary care. It's designed for adults who have frequent migraines (4 to 14 days per month) and have not yet tried a preventive medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have migraines on 4 to 14 days per month (not more than 15 headache days).
- You have never taken a daily medication to prevent migraines before.
- You are not pregnant, breastfeeding, or planning pregnancy in the next 3 months.
- You have a smartphone.
- You do not have certain health conditions like heart block, severe depression, or epilepsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares three common migraine prevention medications to see which works best. You might be able to join if you have migraines at least 4 days a month and haven't taken these specific drugs before.
This trial tests whether a computer algorithm can help pick the best migraine prevention medicine for you. You'll try one of several common preventives and track your headaches.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This study looks at ways to help children and teens with migraine headaches by testing a care approach that includes access to evidence-based treatment. It may help if your child has frequent migraine headaches and is starting (or not already on) certain migraine-preventive medicines.
This trial tests two medicines—flunarizine and propranolol—to see which one works better for preventing migraines in children ages 8 to 15. If your child has frequent migraines that affect their daily life, this study may help find a treatment that works for them.
This trial tests two new migraine medicines, rimegepant and zavegepant, given to people in the emergency department to see how well they work for stopping a migraine headache quickly.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.